Treatment considerations in pulmonary coccidioidomycosis

References

• Fisher MC, Koenig GL, White TJ, et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002 Jan-Feb;94(1):73–84.
   PubMed Web of Science ®Google Scholar
• Ampel NM. The treatment of coccidioidomycosis. Rev Inst Med Trop S Paulo. 2015 Sep;57(Suppl 19):51–56.
   PubMed Web of Science ®Google Scholar
• Engelthaler DM, Roe CC, Hepp CM, et al. Local population structure and patterns of Western hemisphere dispersal for Coccidioides spp.: the fungal cause of valley fever. MBio. 2016;7(2):e00550–e00516.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Valley fever (coccidioidomycosis) statistics. 2016. [cited 2016 Apr 4]. Available from: http://www.cdc.gov/fungal/diseases/coccidioidomycosis/statistics.html
   Google Scholar
• Malo J, Luraschi-Monjagatta C, Wolk DM, et al. Update on the diagnosis of pulmonary coccidioidomycosis. Ann Am Thorac Soc. 2014 Feb;11(2):243–253.
   PubMedGoogle Scholar
• Brown J, Benedict K, Park BJ, et al. Coccidioidomycosis: epidemiology. Clin Epidemiol. 2013;5:185–197.
   PubMedGoogle Scholar
• Tsang CA, Tabnak F, Vugia DJ, et al. Increased in reported coccidioidomycosis: United States, 1998–2011. MMWR Morb Mortal Wkly Rep. 2013 Mar 29;62(12):217–221.
   PubMed Web of Science ®Google Scholar
• Office of Infectious Disease Services, Arizona Department of Health Services. Rates of reported cases of notifiable diseases by year for Arizona, 2004–2014, per 100,000 population. [ cited 2016 Aug 31]. Available from: http://www.azdhs.gov/documents/preparedness/epidemiology-disease-control/disease-data-statistics-reports/rates2004_2014.pdf.
   Google Scholar
• Smith CE, Beard RR. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health Nations Health. 1946 Dec;36(12):1394–1402.
   PubMed Web of Science ®Google Scholar
• Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007 Jan;45(1):26–30.
   PubMed Web of Science ®Google Scholar
• Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis. 2005 Nov 1;41(9):1217–1223.
   PubMed Web of Science ®Google Scholar
• Ampel NM, Giblin A, Mourani JP, et al. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis. 2009 Jan 15;48(2):172–178.
   PubMed Web of Science ®Google Scholar
• Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016 Sep 15;63(6):e112–e146.
   PubMed Web of Science ®Google Scholar
• Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis. 2006 Jun;12(6):958–962.
   PubMed Web of Science ®Google Scholar
• Wang XL, Wang S, An CL. Mini-review of published reports on coccidioidomycosis in China. Mycopathologia. 2015 Dec;180(5–6):299–303.
   PubMed Web of Science ®Google Scholar
• Kim MM, Blair JE, Carey EJ, et al. Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. Emerg Infect Dis. 2009 Mar;15(3):397–401.
   PubMed Web of Science ®Google Scholar
• Ophuls W. Further observations on a pathogenic mould formerly described as a protozoon (Coccidioides immitis, Coccidioides pyogenes). J Exp Med. 1905 Feb 1;6(4–6):443–485.
   PubMedGoogle Scholar
• Johnson RH, Einstein HE. Amphotericin B and coccidioidomycosis. Ann NY Acad Sci. 2007 Sep;1111:434–441.
   PubMed Web of Science ®Google Scholar
• Graybill JR, Lundberg D, Donovan W, et al. Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients. Rev Infect Dis. 1980 Jul-Aug;2(4):661–673.
   PubMedGoogle Scholar
• Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96–128.
   PubMed Web of Science ®Google Scholar
• Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016 Aug 1;63(3):356–362.
   PubMed Web of Science ®Google Scholar
• Fromtling RA. Overview of medically important antifungal azole derivatives. Clin Microbiol Rev. 1988 Apr;1(2):187–217.
   PubMedGoogle Scholar
• Heeres J, Meerpoel L, Lewi P. Conazoles. Molecules. 2010 Jun;15(6):4129–4188.
   PubMed Web of Science ®Google Scholar
• Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev. 1999 Jan;12(1):40–79.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Clemons KV. Azole therapy of clinical and experimental coccidioidomycosis. Ann N Y Acad Sci. 2007 Sep;1111:442–454.
   PubMed Web of Science ®Google Scholar
• Georgopapadakou NH, Walsh TJ. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother. 1996 Feb;40(2):279–291.
   PubMed Web of Science ®Google Scholar
• Bodey GP. Azole antifungal agents. Clin Infect Dis. 1992 Mar;14(Suppl 1):S161–S169.
   PubMed Web of Science ®Google Scholar
• Anderson TM, Clay MC, Cioffi AG, et al. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol. 2014 May;10(5):400–406.
   PubMed Web of Science ®Google Scholar
• Antony S, Dominguez DC, Sotelo E. Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis. J Natl Med Assoc. 2003 Oct;95(10):982–985.
   PubMed Web of Science ®Google Scholar
• Aguilar-Zapata D, Petraitiene R, Petraitis V. Echinocandins: the expanding antifungal armamentarium. Clin Infect Dis. 2015 Dec 1;61(Suppl 6):S604–S611.
   PubMed Web of Science ®Google Scholar
• Spinello IM, Johnson RH, Baqi S. Coccidioidomycosis and pregnancy: a review. Ann N Y Acad Sci. 2007 Sep;1111:358–364.
   PubMed Web of Science ®Google Scholar
• Koehler AP, Cheng AF, Chu KC, et al. Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. J Infect. 1998 Jan;36(1):113–115.
   PubMed Web of Science ®Google Scholar
• Sugar AM. Antifungal combination therapy: where we stand. Drug Resist Updat. 1998;1(2):89–92.
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Lamoth F, Juvvadi PR. Potential microbiological effects of higher dosing of echinocandins. Clin Infect Dis. 2015 Dec 1;61(Suppl 6):S669–S677.
   PubMed Web of Science ®Google Scholar
• Merck & Co. Candicas: highlights of prescribing information. 2009. [cited 2016 Aug 24]. Available from: https://www.merck.com/product/usa/pi_circulars/c/cancidas/cancidas_pi.pdf
   Google Scholar
• Astellas Pharma Tech Co. Highlights of prescribing information (mycamine). 2013. [cited 2016 Aug 30]. Available from: https://www.astellas.us/docs/mycamine.pdf
   Google Scholar
• Roerig, Division of Pfizer. Highlights of prescribing information (eraxis). 2013. [ cited 2016 Aug 30]. Available from: http://labeling.pfizer.com/ShowLabeling.aspx?id=566
   Google Scholar
• Gonzalez GM, Tijerina R, Najvar LK, et al. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother. 2001 Jun;45(6):1854–1859.
   PubMed Web of Science ®Google Scholar
• Gonzalez GM, Gonzalez G, Najvar LK, et al. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model. J Antimicrob Chemother. 2007 Dec;60(6):1341–1346.
   PubMed Web of Science ®Google Scholar
• Park DW, Sohn JW, Cheong HJ, et al. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. BMC Infect Dis. 2006;6:26.
   PubMed Web of Science ®Google Scholar
• Hsue G, Napier JT, Prince RA, et al. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrobial Chemother. 2004 Jul;54(1):292–294.
   PubMed Web of Science ®Google Scholar
• Antony S. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis. 2004 Sep 15;39(6):879–880.
   PubMed Web of Science ®Google Scholar
• Levy ER, McCarty JM, Shane AL, et al. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Clin Infect Dis. 2013 Jun;56(11):1573–1578.
   PubMed Web of Science ®Google Scholar
• McCarty JM, Demetral LC, Dabrowski L, et al. Pediatric coccidioidomycosis in central California: a retrospective case series. Clin Infect Dis. 2013 Jun;56(11):1579–1585.
   PubMed Web of Science ®Google Scholar
• Galgiani JN. Elements of style in managing coccidioidomycosis. Clin Infect Dis. 2013 Jun;56(11):1586–1588.
   PubMed Web of Science ®Google Scholar
• Ampel NM. Coccidioidomycosis: a review of recent advances. Clin Chest Med. 2009 Jun;30(2):241–251.
   PubMed Web of Science ®Google Scholar
• Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2005 Aug 15;41(4):e38–e41.
   PubMed Web of Science ®Google Scholar
• Duplessis CA, Tilley D, Bavaro M, et al. Two cases illustrating successful adjunctive interferon-gamma immunotherapy in refractory disseminated coccidioidomycosis. J Infect Dis. 2011 Sep;63(3):223–228.
   Google Scholar
• Kuberski TT, Servi RJ, Rubin PJ. Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma. Clin Infect Dis. 2004 Mar 15;38(6):910–912.
   PubMed Web of Science ®Google Scholar
• Horizon Pharma Ireland Ltd. Actimmune: highlights of prescribing information. [ cited 2016 Aug 24]. Available from: http://www.actimmune.com/pdf/10889_Actimmune-PI_8_5x11.pdf
   Google Scholar
• UpToDate. Interferon gamma-1b: drug information. [ cited 2016 Aug 16]. Available from: http://www.uptodate.com/contents/interferon-gamma-1b-drug-information?source=search_result&search=interferon+gamma+1b&selectedTitle=1~17#F16323199
   Google Scholar
• Blair JE, Chang YH, Cheng MR, et al. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014 Jun;20(6):983–990.
   PubMed Web of Science ®Google Scholar
• Twarog M, Thompson GR 3rd. Coccidioidomycosis: recent updates. Semin Respir Crit Care Med. 2015 Oct;36(5):746–755.
   PubMed Web of Science ®Google Scholar
• Chang DC, Anderson S, Wannemuehler K, et al. Testing for coccidioidomycosis among patients with community-acquired pneumonia. Emerg Infect Dis. 2008 Jul;14(7):1053–1059.
   PubMed Web of Science ®Google Scholar
• Dickson EC. “Valley fever” of the San Joaquin Valley and fungus coccidioides. Cal West Med. 1937 Sep;47(3):151–155.
   PubMedGoogle Scholar
• Dickson EC, Gifford MA. Coccidioides infection (coccidioidomycosis): the primary type of infection. Arch Intern Med. 1938 Nov;62(5):853–871.
   Google Scholar
• Galgiani JN. Coccidioidomycosis: changing perceptions and creating opportunities for its control. Ann N Y Acad Sci. 2007 Sep;1111:1–18.
   PubMed Web of Science ®Google Scholar
• Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. Am J Med. 1995 Mar;98(3):249–256.
   PubMed Web of Science ®Google Scholar
• Diaz M, Puente R, De Hoyos LA, et al. Itraconazole in the treatment of coccidioidomycosis. Chest. 1991 Sep;100(3):682–684.
   PubMed Web of Science ®Google Scholar
• Prabhu RM, Bonnell M, Currier BL, et al. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004 Oct 1;39(7):e74–e77.
   PubMed Web of Science ®Google Scholar
• Anstead GM, Corcoran G, Lewis J, et al. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis. 2005 Jun 15;40(12):1770–1776.
   PubMed Web of Science ®Google Scholar
• Clark NM, Grim SA, Lynch JP 3rd. Posaconazole: use in the prophylaxis and treatment of fungal infections. Semin Respir Crit Care Med. 2015 Oct;36(5):767–785.
   PubMed Web of Science ®Google Scholar
• Larsen RA, Jacobson JA, Morris AH, et al. Acute respiratory failure caused by primary pulmonary coccidioidomycosis: two case reports and a review of the literature. Am Rev Respir Dis. 1985 May;131(5):797–799.
   PubMed Web of Science ®Google Scholar
• Arsura EL, Kilgore WB. Miliary coccidioidomycosis in the immunocompetent. Chest. 2000 Feb;117(2):404–409.
   PubMed Web of Science ®Google Scholar
• Batra P. Pulmonary coccidioidomycosis. J Thorac Imaging. 1992 Sep;7(4):29–38.
   PubMed Web of Science ®Google Scholar
• Lonky SA, Catanzaro A, Moser KM, et al. Acute coccidioidal pleural effusion. Am Rev Respir Dis. 1976 Oct;114(4):681–688.
   PubMed Web of Science ®Google Scholar
• Takamura M, Stark P. Diagnostic case study: coccidioidomycosis: pleural involvement. Semin Respir Infect. 2001 Dec;16(4):280–285.
   PubMedGoogle Scholar
• Thompson GR 3rd. Pulmonary coccidioidomycosis. Semin Respir Crit Care Med. 2011 Dec;32(6):754–763.
   PubMed Web of Science ®Google Scholar
• Cunningham RT, Einstein H. Coccidioidal pulmonary cavities with rupture. J Thorac Cardiovasc Surg. 1982 Aug;84(2):172–177.
   PubMed Web of Science ®Google Scholar
• Jaroszewski DE, Halabi WJ, Blair JE, et al. Surgery for pulmonary coccidioidomycosis: a 10-year experience. Ann Thorac Surg. 2009 Dec;88(6):1765–1772.
   PubMed Web of Science ®Google Scholar
• Lopez AM, Williams PL, Ampel NM. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: a report of two cases. Am J Med. 1993 Aug;95(2):236–239.
   PubMed Web of Science ®Google Scholar
• Arsura EL, Bellinghausen PL, Kilgore WB, et al. Septic shock in coccidioidomycosis. Crit Care Med. 1998 Jan;26(1):62–65.
   PubMed Web of Science ®Google Scholar
• Horita N, Hashimoto S, Miyazawa N, et al. Impact of corticosteroids on mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Intern Med. 2015;54(12):1473–1479.
   PubMed Web of Science ®Google Scholar
• Peter JV, John P, Graham PL, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ. 2008 May 3;336(7651):1006–1009.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007 Apr;131(4):954–963.
   PubMed Web of Science ®Google Scholar
• Malo J, Raz Y, Snyder L, et al. Treatment of coccidioidomycosis-associated eosinophilic pneumonia with corticosteroids. Southwest J Respir Crit Care. 2012;4:61–66.
   Google Scholar
• Flores-Franco RA, Aguayo-Yong R. Primary coccidioidal pleural effusions successfully treated with adjunctive corticosteroid therapy. Respiration. 2010;79(1):85–86.
   PubMed Web of Science ®Google Scholar
• Hage CA, Azar MM, Bahr N, et al. Histoplasmosis: up-to-date evidence-based approach to diagnosis and management. Semin Respir Crit Care Med. 2015 Oct;36(5):729–745.
   PubMed Web of Science ®Google Scholar
• Wynne JW, Olsen GN. Acute histoplasmosis presenting as the adult respiratory distress syndrome. Chest. 1974 Aug;66(2):158–161.
   PubMed Web of Science ®Google Scholar
• Shibli M, Ghassibi J, Hajal R, et al. Adjunctive corticosteroids therapy in acute respiratory distress syndrome owing to disseminated coccidioidomycosis. Crit Care Med. 2002 Aug;30(8):1896–1898.
   PubMed Web of Science ®Google Scholar
• Galgiani JN. Coccidioidomycosis. West J Med. 1993 Aug;159(2):153–171.
   PubMedGoogle Scholar
• Smith CE, Beard RR, Saito MT. Pathogenesis of coccidioidomycosis with special reference to pulmonary cavitation. Ann Intern Med. 1948 Oct;29(4):623–655.
   PubMed Web of Science ®Google Scholar
• Sobonya RE, Yanes J, Klotz SA. Cavitary pulmonary coccidioidomycosis: pathologic and clinical correlates of disease. Hum Pathol. 2014 Jan;45(1):153–159.
   PubMed Web of Science ®Google Scholar
• Bayer AS. Fungal pneumonias: pulmonary coccidioidal syndromes (part 2). Miliary, nodular, and cavitary pulmonary coccidioidomycosis; chemotherapeutic and surgical considerations. Chest. 1981 Jun;79(6):686–691.
   PubMed Web of Science ®Google Scholar
• Bayer AS, Yoshikawa TT, Galpin JE, et al. Unusual syndromes of coccidioidomycosis: diagnostic and therapeutic considerations; a report of 10 cases and review of the English literature. Medicine. 1976 Mar;55(2):131–152.
   PubMed Web of Science ®Google Scholar
• Harris RE. Coccidioidomycosis complicating pregnancy: report of 3 cases and review of the literature. Obstet Gynecol. 1966 Sep;28(3):401–405.
   PubMed Web of Science ®Google Scholar
• Vaughan JE, Ramirez H. Coccidioidomycosis as a complication of pregnancy. Calif Med. 1951 Feb;74(2):121–125.
   PubMedGoogle Scholar
• Wack EE, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during pregnancy: an analysis of ten cases among 47,120 pregnancies. Chest. 1988 Aug;94(2):376–379.
   PubMed Web of Science ®Google Scholar
• Caldwell JW, Arsura EL, Kilgore WB, et al. Coccidioidomycosis in pregnancy during an epidemic in California. Obstet Gynecol. 2000 Feb;95(2):236–239.
   PubMed Web of Science ®Google Scholar
• Pursley TJ, Blomquist IK, Abraham J, et al. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis. 1996 Feb;22(2):336–340.
   PubMed Web of Science ®Google Scholar
• Krcmery V Jr., Huttova M, Masar O. Teratogenicity of fluconazole. Pediatr Infect Dis J. 1996 Sep;15(9):841.
   PubMed Web of Science ®Google Scholar
• Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med. 2013 Aug 29;369(9):830–839.
   PubMed Web of Science ®Google Scholar
• Molgaard-Nielsen D, Svanstrom H, Melbye M, et al. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA. 2016 Jan 5;315(1):58–67.
   PubMed Web of Science ®Google Scholar
• Bercovitch RS, Catanzaro A, Schwartz BS, et al. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis. 2011 Aug;53(4):363–368.
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF, Truett AA, Teneza-Mora N, et al. Unusual presentations of coccidioidomycosis: a case series and review of the literature. Medicine. 2006 Sep;85(5):263–277.
   PubMed Web of Science ®Google Scholar
• Ampel NM. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis. 2005 Oct 15;41(8):1174–1178.
   PubMed Web of Science ®Google Scholar
• Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010 Jan 1;50(1):1–7.
   PubMed Web of Science ®Google Scholar
• Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis. 2000 Apr;181(4):1428–1434.
   PubMed Web of Science ®Google Scholar
• Jones JL, Fleming PL, Ciesielski CA, et al. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis. 1995 Apr;171(4):961–966.
   PubMed Web of Science ®Google Scholar
• Huang JY, Bristow B, Shafir S, et al. Coccidioidomycosis-associated deaths: United States, 1990-2008. Emerg Infect Dis. 2012 Nov;18(11):1723–1728.
   PubMed Web of Science ®Google Scholar
• Ashbee HR, Barnes RA, Johnson EM, et al. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014 May;69(5):1162–1176.
   PubMed Web of Science ®Google Scholar
• AIDSinfo.nih.gov. [ cited 2016 Apr 13]. Available from: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0.
   Google Scholar
• US National Institutes of Health. Early fluconazole treatment for coccidioidomycosis pneumonia. 2016. [cited 2016 Mar 25]. Available from: https://clinicaltrials.gov/ct2/show/NCT02663674?term=valley+fever&rank=6.
   Google Scholar
• Mertz LE, Blair JE. Coccidioidomycosis in rheumatology patients: incidence and potential risk factors. Ann N Y Acad Sci. 2007 Sep;1111:343–357.
   PubMed Web of Science ®Google Scholar
• Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001 Nov 1;33(9):1536–1544.
   PubMed Web of Science ®Google Scholar
• Vucicevic D, Carey EJ, Blair JE. Coccidioidomycosis in liver transplant recipients in an endemic area. Am J Transplant. 2011 Jan;11(1):111–119.
   PubMed Web of Science ®Google Scholar
• Kahn A, Carey EJ, Blair JE. Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area. Liver Transpl. 2015 Mar;21(3):353–361.
   PubMed Web of Science ®Google Scholar
• Mendoza N, Noel P, Blair JE. Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation. Transpl Infect Dis. 2015 Jun;17(3):380–388.
   PubMed Web of Science ®Google Scholar
• Mori T, Aisa Y, Kato J, et al. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transpl. 2009 Sep;44(6):371–374.
   PubMed Web of Science ®Google Scholar
• Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006 Nov;119(11):964–969.
   PubMed Web of Science ®Google Scholar
• Baker EJ, Hawkins JA, Waskow EA. Surgery for coccidioidomycosis in 52 diabetic patients with special reference to related immunologic factors. J Thorac Cardiovasc Surg. 1978 May;75(5):680–687.
   PubMed Web of Science ®Google Scholar
• Pappagianis D. Opportunism in coccidioidomycosis. In: Chick E, Balows A, Furcolow ML, editors. Opportunistic fungal infections. Springfield (IL): Charles C. Thomas; 1975. p. 221–234.
   Google Scholar
• Gupta S, Koirala J, Khardori R, et al. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am. 2007 Sep;21(3):617–638.
   PubMed Web of Science ®Google Scholar
• Blair JE, Smilack JD, Caples SM. Coccidioidomycosis in patients with hematologic malignancies. Archiv Intern Med. 2005 Jan 10;165(1):113–117.
   PubMedGoogle Scholar
• Rowland VS, Westfall RE, Hinchcliffe WA. Fatal coccidioidomycosis: analysis of host factors in coccidioidomycosis: current clinical and diagnostic status. Symp Spec. 1977;91–106.
   Google Scholar
• Torres HA, Rivero GA, Kontoyiannis DP. Endemic mycoses in a cancer hospital. Medicine. 2002 May;81(3):201–212.
   PubMed Web of Science ®Google Scholar
• Fitterer C, Berg Z, Halfdanarson TR, et al. Coccidioidomycosis in patients with selected solid organ cancers: a case series and review of medical literature. Mycopathologia. 2016 Aug 4.
   PubMed Web of Science ®Google Scholar
• Ordonez ME, Farraye FA, Di Palma JA. Endemic fungal infections in inflammatory bowel disease associated with anti-TNF antibody therapy. Inflamm Bow Dis. 2013 Oct;19(11):2490–2500.
   PubMed Web of Science ®Google Scholar
• Taroumian S, Knowles SL, Lisse JR, et al. Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs. Arthritis Care Res. 2012 Dec;64(12):1903–1909.
   Web of Science ®Google Scholar
• Chen S, Erhart LM, Anderson S, et al. Coccidioidomycosis: knowledge, attitudes, and practices among healthcare providers, Arizona, 2007. Med Mycol. 2011 Aug;49(6):649–656.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Valley fever: working toward a solution. [cited 2013 Sep 23]. Available from: http://www.cdc.gov/features/valleyfevercalifornia/.
   Google Scholar
• The University of Arizona, Valley Fever Center for Excellence. Coccidioidomycosis. 2010. [cited 2016 Aug 30]. Available from: http://www.vfce.arizona.edu/.
   Google Scholar